Sunshine Biopharma Inc. Notes Payable, Current
Sunshine Biopharma Inc. (SBFM) had Notes Payable, Current of $0 as of 2021-12-31, per its 10-K filed 2022-03-21.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current
us-gaap:NotesPayableCurrent · last filed 2022-03-21
- 2021-12-31: Notes Payable, Current $0.00.
- 2021-09-30: Notes Payable, Current $330.00K.
- 2021-06-30: Notes Payable, Current $330.00K.
- 2021-03-31: Notes Payable, Current $521.03K.
| Period end | Notes Payable, Current | Notes Payable, Current as first filed |
|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-21 | |
| 2021-09-30 | $330.00K 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $330.00K 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $521.03K 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $820.45K 10-K · filed 2022-03-21 | |
| 2020-09-30 | $530.21K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $357.31K 10-Q/A · filed 2020-08-31 | $439.50K 10-Q · filed 2020-08-19 |
| 2020-03-31 | $513.41K 10-Q · filed 2020-05-18 | |
| 2019-12-31 | $586.31K 10-K · filed 2021-03-30 | |
| 2019-09-30 | $662.92K 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $688.98K 10-Q · filed 2019-08-15 | |
| 2019-03-31 | $745.40K 10-Q · filed 2019-05-20 | |
| 2018-12-31 | $419.66K 10-K · filed 2020-05-01 | |
| 2018-09-30 | $361.05K 10-Q · filed 2018-11-16 | |
| 2018-06-30 | $719.73K 10-Q · filed 2018-08-17 | |
| 2018-03-31 | $785.14K 10-Q · filed 2018-05-22 | |
| 2017-12-31 | $516.87K 10-K · filed 2019-04-12 | |
| 2017-09-30 | $391.57K 10-Q · filed 2017-11-15 | |
| 2017-06-30 | $213.36K 10-Q · filed 2017-08-11 | |
| 2017-03-31 | $71.44K 10-Q · filed 2017-05-12 | |
| 2016-12-31 | $69.94K 10-K · filed 2018-04-02 | |
| 2016-09-30 | $248.99K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $324.14K 10-Q · filed 2016-08-16 | |
| 2016-03-31 | $269.14K 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $102.14K 10-K · filed 2017-04-17 | $305.18K 10-K · filed 2016-03-25 |
| 2015-09-30 | $418.64K 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $390.64K 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $313.13K 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $480.12K 10-K · filed 2016-03-25 | |
| 2014-09-30 | $396.00K 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $282.50K 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $132.50K 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $12.50K 10-K · filed 2015-03-11 | |
| 2013-09-30 | $12.50K 10-Q · filed 2013-11-04 | |
| 2013-06-30 | $12.50K 10-Q · filed 2013-08-06 | |
| 2013-03-31 | $12.50K 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $62.50K 10-K · filed 2014-03-19 | |
| 2012-09-30 | $12.50K 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $12.50K 10-Q · filed 2012-08-08 | |
| 2012-03-31 | $12.50K 10-Q · filed 2012-05-08 | |
| 2011-12-31 | $0.00 10-Q · filed 2012-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |